LabCorp Covid-19 Molecular Test Innovation Gets FDA EUA
LabCorp’s new, high-throughput method uses heat and technology to extract RNA from samples collected for covid-19 molecular testing.
Read MorePosted by Melanie Hamilton-Basich | Oct 7, 2020 | Covid 19, Molecular Diagnostics |
LabCorp’s new, high-throughput method uses heat and technology to extract RNA from samples collected for covid-19 molecular testing.
Read MorePosted by Melanie Hamilton-Basich | Oct 7, 2020 | Covid 19, Immunoassay Reagents & test Kits |
The novel kit combines a liquid-based sample preparation step completed in 2 minutes with real-time PCR detection in a streamlined workflow.
Read MorePosted by Laurie Bonner | Oct 7, 2020 | Covid 19, Miscellaneous |
The letter asks for transparency into the allocation and availability of covid-19 testing supplies, reagents, and other materials, such as test kits and pipette tips.
Read MorePosted by Melanie Hamilton-Basich | Oct 7, 2020 | Covid 19, Rapid Assays |
Covid-19 antigen tests may not detect all cases, but they are inexpensive and people can use them at home, unlike other much less accessible tests.
Read MorePosted by Laurie Bonner | Oct 7, 2020 | Company News, Covid 19 |
The goal of the Covid-19 Testing Industry Consortium is to inform, improve, innovate, and accelerate various aspects of testing, ranging from research to clinical diagnostic applications.
Read More